Citation Impact
Citing Papers
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1
2007
The CCR5 and CXCR4 Coreceptors—Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection
2004
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
1997 Standout
Retroviral superinfection resistance
2005
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
2012 Standout
Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA
2007
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Sexual Transmission of Hepatitis C Virus among Patients Attending Sexually Transmitted Diseases Clinics in Baltimore--An Analysis of 309 Sex Partnerships
1995
HIV-1 Nef Induces Dendritic Cell Differentiation: A Possible Mechanism of Uninfected CD4+ T Cell Activation
2002
The digoxigenin:anti-digoxigenin (DIG) technology—a survey on the concept and realization of a novel bioanalytical indicator system
1991
The basis for HIV immunotherapeutic vaccines
2001
Structure-Based Design of Novel HIV Protease Inhibitors: Carboxamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Nonpeptidic Inhibitors
1995
Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials
2001
Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells
2011
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Nonhuman Primates: A Critical Role in Current Disease Research
2001
A tick-borne rickettsia of the spotted-fever group, similar toRickettsia amblyommii, in French Guyana
2007
Angiogenesis in health and disease
2003 Standout
Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model
2005
Epidemiology of hepatitis C
1997 Standout
Fanconi syndrome and renal failure induced by tenofovir: A first case report
2002
A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
2016 StandoutNobel
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
2000 Nature
Molecular biology of the Bunyaviridae
1990 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
2002 StandoutNature
Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: a case-control study.
1994
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection
2010
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness
2008 StandoutNobel
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
The cytopathic effect of hiv is associated with apoptosis
1991 StandoutNobel
Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors
2004
New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview
1999
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
2006 Standout
Zika Virus and Birth Defects — Reviewing the Evidence for Causality
2016 Standout
The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines
2004
Preparation of Clinical‐Grade Recombinant Canarypox–Human Immunodeficiency Virus Vaccine–Loaded Human Dendritic Cells
2002 StandoutNobel
Full-Length Sequence of an Ethiopian Human Immunodeficiency Virus Type 1 (HIV-1) Isolate of Genetic Subtype C
1996
AIDS virus infection and autoimmunity: A perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease
1991
Non-isotopic RNA probes
1989
Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science
2001 Standout
Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus
2006 StandoutNobel
Rocky Mountain spotted fever
2007
Arboviruses Pathogenic for Domestic and Wild Animals
2014
Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
1992 Standout
Vaccines for the prevention of HIV-1 disease
2001
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Impact of high-throughput screening in biomedical research
2011 Standout
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Persistent infection of Aedes albopictus C6/36 cells by Bunyamwera virus
1986
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Synthesis and Function of 3-Phosphorylated Inositol Lipids
2001 Standout
Vaccine Protection against Simian Immunodeficiency Virus by Recombinant Strains of Herpes Simplex Virus
2000
The Genus Phlebovirus and its Vectors
1988
A Comprehensive Panel of Near-Full-Length Clones and Reference Sequences for Non-Subtype B Isolates of Human Immunodeficiency Virus Type 1
1998 StandoutNobel
Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination
1999 Standout
Complex networks: Structure and dynamics
2006 Standout
AIDS-Related Malignancies
2003
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Alterations of thymus cortical epithelium and interdigitating dendritic cells but no increase of thymocyte cell death in the early course of simian immunodeficiency virus infection.
1993
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
2000 Standout
Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma
2002
Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4+CD8−CD3+ thymocytes through sustained induction of Bcl-2
2001 StandoutNobel
Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines
2007 StandoutNobel
Human Immunodeficiency Virus Type 1 Vif Protein Is an Integral Component of an mRNP Complex of Viral RNA and Could Be Involved in the Viral RNA Folding and Packaging Process
2000
Contact with Thymic Epithelial Cells as a Prerequisite for Cytokine-Enhanced Human Immunodeficiency Virus Type 1 Replication in Thymocytes
1998 StandoutNobel
Long oligonucleotide microarrays for African green monkey gene expression profile analysis
2007 StandoutNobel
Thymocyte-Thymic Epithelial Cell Interaction Leads to High-Level Replication of Human Immunodeficiency Virus Exclusively in Mature CD4+CD8−CD3+Thymocytes: a Critical Role for Tumor Necrosis Factor and Interleukin-7
1999 StandoutNobel
Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic Studies
2006
Tick-Borne Rickettsioses around the World: Emerging Diseases Challenging Old Concepts
2005
Epidemiological parameters of HI V transmission
1988 Nature
Rapid and simple method for purification of nucleic acids
1990 Standout
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection
2004 StandoutNobel
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro
1994 StandoutNobel
Dynamic Distribution of Chemoattractant Receptors in Living Cells During Chemotaxis and Persistent Stimulation
1997
Update on Tick-Borne Rickettsioses around the World: a Geographic Approach
2013 Standout
Peripheral Blood-Derived CD34+ Progenitor Cells: CXC Chemokine Receptor 4 and CC Chemokine Receptor 5 Expression and Infection by HIV
1998
Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine
1999
Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells
2002 StandoutNobel
Diagnostic deoxyribonucleic acid probes for infectious diseases
1988
First identification of natural infection of Rickettsia rickettsii in the Rhipicephalus sanguineus tick, in the State of Rio de Janeiro
2009
Virus and Autoimmunity: Induction of Autoimmune Disease in Mice by Mouse T Lymphotropic Virus (MTLV) Destroying CD4+ T Cells
1999 StandoutNobel
Works of P. Verani being referenced
Long-Lasting Protection by Live Attenuated Simian Immunodeficiency Virus in Cynomolgus Monkeys: No Detection of Reactivation after Stimulation with a Recall Antigen
1999
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine
2000
Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIVmacJ5 on the kinetics of SIV replication in cynomolgus monkeys
2001
HIV env glycoprotein shares a cross‐reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation
1987
Full expression of transfected nonproducer interfering HIV-1 proviral DNAabrogates susceptibility of human He-La CD4+ cells to HIV
1995
DNA Immunization of Mice against SIVmac239 Gag and Env Using Rev-Independent Expression Plasmids
1998
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
1999
Human immunodeficiency virus (HIV) seropositivity in intravenous (IV) drug abusers in three cities of Italy: Possible natural history of HIV infection in IV drug addicts in Italy
1987
Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1
1991
Serological survey of human immunodeficiency virus (hiv) in ethiopia
1989
CD4 defect without HIV in patients with opportunistic infections of Kaposiʼs sarcoma131
1993
T-tropic human immunodeficiency virus (HIV) type 1 Nef protein enters human monocyte–macrophages and induces resistance to HIV replication: a possible mechanism of HIV T-tropic emergence in AIDS
2000
AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide and cyclosporin.
1992
Dideoxyinosine-associated nephrotoxicity
1993
Isolation of Bhanja Virus from Haemaphysalis Ticks in Italy
1970
cisExpression of the F12 Human Immunodeficiency Virus (HIV) Nef Allele Transforms the Highly Productive NL4-3 HIV Type 1 to a Replication-Defective Strain: Involvement of both Env gp41 and CD4 Intracytoplasmic Tails
2000
Establishment and Maintenance of Persistent Infection by the Phlebovirus Toscana in Vero Cells
1984
Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes
2002
Hepatitis B and C viruses, human T-cell lymphotropic virus types I and II, and leukemias: a case-control study. The Italian Leukemia Study Group.
1996
In situ hybridization of human immunodeficiency virus (HTLV‐III) in cryostat sections of lymph nodes of lymphadenopathy syndrome patients
1987
Experimental pathogenicity of Bhanja virus for white mice and Macaca mulatta monkeys.
1970
Growth of Two Phleboviruses after Experimental Infection of their Suspected Sand Fly Vector, Phlebotomus perniciosus (Diptera: Psychodidae)
1985
Human Immunodeficiency Virus (HIV)-Resistant CD4+ UT-7 Megakaryocytic Human Cell Line Becomes Highly HIV-1 and HIV-2 Susceptible Upon CXCR4 Transfection: Induction of Cell Differentiation by HIV-1 Infection
1997
gag , vif , and nef Genes Contribute to the Homologous Viral Interference Induced by a Nonproducer Human Immunodeficiency Virus Type 1 (HIV-1) Variant: Identification of Novel HIV-1-Inhibiting Viral Protein Mutants
1998